来源 :金融界2022-01-11
【财华社讯】港交所权益资料显示，昭衍新药(06127.HK)获Aggregate of abrdn plc affiliated investment management entities于1月7日在场內以每股平均价54.0177港元增持24.68万股，涉资约1333.16万港元。增持后，Aggregate of abrdn plc affiliated investment management entities的最新持股数目为364.70万股，持股比例由5.60%增持至6.01%。